C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2001
11/01/2001	US20010036647 Genetic engineering
11/01/2001	US20010036643 Educational kit and method using tumor necrosis factor-stimulated gene and protein
11/01/2001	US20010036642 Antibodies specific for papillary fibroblasts as markers for skin quality
11/01/2001	US20010036629 Sequencing of surface immobilized polymers utilizing microfluorescence detection
11/01/2001	US20010036459 Cytotoxicity; therapeutic antibody
11/01/2001	US20010036457 Anticancer agents
11/01/2001	EP1144642A3 Compounds and methods for treatment and diagnosis of chlamydial infection
11/01/2001	CA2410024A1 Identification and uses of a hyaluronan receptor
11/01/2001	CA2407517A1 Equine protozoal myeloencephalitis vaccine
11/01/2001	CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001	CA2407455A1 Immunogenic pneumococcal protein and vaccine compositions thereof
11/01/2001	CA2407352A1 Compositions and methods for the therapy and diagnosis of acne vulgaris
11/01/2001	CA2407336A1 Method for treatment of tumors using photodynamic therapy
11/01/2001	CA2407167A1 Thrombopoietin receptor modulating peptide
11/01/2001	CA2407084A1 Isolated human transporter proteins, nucleic acids and uses thereof
11/01/2001	CA2407081A1 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof
11/01/2001	CA2407077A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
11/01/2001	CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	CA2406264A1 Protein phosphatases
11/01/2001	CA2405985A1 Nk-2 homeobox transcription factor
11/01/2001	CA2405961A1 Bispecific molecules and uses thereof
11/01/2001	CA2405680A1 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
11/01/2001	CA2405632A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
11/01/2001	CA2405138A1 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors
10/2001
10/31/2001	EP1150121A2 Method of obtaining diagnostic reagents, assays and therapeutics based on clinical manifestations of a disease
10/31/2001	EP1149914A2 A fusion protein that recognizes human autoantibodies simultanoeously
10/31/2001	EP1149913A1 Cytokine immunoconjugates
10/31/2001	EP1149908A1 TGF-beta type receptor cDNAs and uses thereof
10/31/2001	EP1149906A1 Thrombopoietin receptor modulating peptide
10/31/2001	EP1149905A1 Methods and compositions for polypeptide engineering
10/31/2001	EP1149904A1 Methods and compositions for polypeptide engineering
10/31/2001	EP1149590A1 Use of gut peptide antibodies to improve feed efficiency
10/31/2001	EP1149166A2 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI)
10/31/2001	EP1149165A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof
10/31/2001	EP1149164A2 Neisseria meningitidis polypeptides
10/31/2001	EP1149115A1 METHODS OF ELICITING BROADLY NEUTRALIZING ANTIBODIES TARGETING HIV-1 gp41
10/31/2001	EP1149114A2 Polypeptides involved in immune response
10/31/2001	EP1149112A2 Ewing's tumour antigen, nucleic acid and antibodies
10/31/2001	EP1149111A1 Method and composition for angiogenesis inhibition
10/31/2001	EP0815141B1 Antibodies active against a fusion polypeptide comprising a histidine portion
10/31/2001	EP0803065B1 A-protein as a diagnostic of cancer
10/31/2001	EP0784621B1 Quinidine conjugates and their use in immunoassays
10/31/2001	EP0699077B1 Hiv immunogenic complexes
10/31/2001	EP0693085B1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof
10/31/2001	EP0519001B1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
10/31/2001	EP0444181B1 C-erbb-2 external domain: gp75
10/31/2001	EP0201540B2 Envelope antigens of lymphadenopathy associated virus and their applications
10/31/2001	DE10020034A1 Mittel zur Diagnose und Therapie von Karzinomen Means for diagnosis and therapy of carcinomas
10/31/2001	DE10018403A1 Preparing vaccine against cancer, useful for treatment or prevention, comprises coupling antibody mimetopes,selected from a phage-display library, to macromolecular carrier
10/31/2001	CN1320045A Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke
10/31/2001	CN1320044A Combination therapies for B-cell lymphomas comprising administration of anti-CD 20 antibody
10/31/2001	CN1320032A Alginate capsules for use in the treatment of brain tumor
10/31/2001	CN1319666A Human testis development relative gene coding protein
10/31/2001	CN1319665A Human testics kinesin 9 gene coding protein
10/31/2001	CN1319662A Human testicular ubiquitin specific proteinase-10 gene coding protein
10/31/2001	CN1319660A Human testis specific protein kinase gene coding protein
10/31/2001	CN1319659A Novel polypeptide-human lysyloxidase 33 and polynucleotide for encoding said polypeptide
10/31/2001	CN1319611A Novel polypeptide-human MAGE antigen 51 and polynucleotide for encoding said polypeptide
10/31/2001	CN1319607A Novel polypeptide-human anky rin homoplastic protein 57 and polynucleotide for coding said polypeptide
10/31/2001	CN1319604A Novel polypeptide-ribosomal protein L15e25 and polynucleotide for encoding said polypeptide
10/31/2001	CN1319603A Novel polypeptide-geminivirus motion protein 19 and polynucloetide for encoding said polypeptide
10/30/2001	US6310190 USPA1 and USPA2 antigens of Moraxella catarrhalis
10/30/2001	US6310185 Immunoglobulin for use in the diagnosis and treatment of cancers
10/30/2001	US6310184 Immunoglobulin for the treatment and prevention of mammary and prostate gland cancers
10/30/2001	US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001	US6310177 Compounds and methods for modulating tissue permeability
10/30/2001	US6310046 Encoded by isolated dna; diagnosis of and immunization against malaria
10/30/2001	US6309892 Detecting immunoglobulins in sample; incubate sample with dense microspheres, monitor and measure immune reponse
10/30/2001	US6309883 Methods and compositions for cellular and metabolic engineering
10/30/2001	US6309881 Aldehyde and ketone reactants are contacted with antibody molecules or molecules containing antibody combining site portions that catalyze an aldol addition reaction
10/30/2001	US6309880 Antibodies specific for CD4-binding domain of HIV-1
10/30/2001	US6309877 Polynucleotides encoding motoneuronotrophic factors
10/30/2001	US6309866 6-phosphogluconate dehydrogenase
10/30/2001	US6309863 Immunizing an animal with the synthetic polypeptide which isa mimetic of the particular amino acid and is phosphorylated, collecting serum or ascitic fluid from immunized animal, screening for presence of antibodies specific for polypeptide
10/30/2001	US6309856 Human MAD proteins and uses thereof
10/30/2001	US6309854 Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72
10/30/2001	US6309853 Nucleotide sequences coding polypeptide associated with contolling bdy weight; for use in diagnosis and treatment of eating disorders
10/30/2001	US6309844 Immunoglobulin for use in the treatment and diagnosis of hyperlipidemia and arterial sclerosis
10/30/2001	US6309826 Diagnosing tumors; monitor tumorous tissue for nucleotide sequences coding tumor glycoprotein, compare to amount of nucleotide sequences coding tumor glycoprotein in healthy sample, classify cells
10/30/2001	US6309649 The fusion (f) protein, attachment (g) protein and matrix (m) protein of respiratory syncytial virus (rsv) are isolated and purified.
10/30/2001	US6309648 Induces formation of protective antibodies against an infection by a bacteria selected from the group consisting of b. pertussis, b. parapertussis, and b. bronchiseptica when administered to a human or animal host.
10/30/2001	US6309644 Parasitic nematode transglutaminase proteins and uses thereof
10/30/2001	US6309643 Diagnosis and treatment of inflammatory bowel disease using microbial antigens.
10/30/2001	US6309642 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
10/30/2001	US6309641 Which can be used immunologically as a vaccine for leptospirosis caused by this organism.
10/30/2001	US6309640 Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
10/30/2001	US6309639 Administering an antibody to a protein component or to a carbohydrate-protein component of p-selectin glycoprotein ligand, the glycoprotein ligand comprising a fucosylated sialylated glycoprotein containing sialyl lewis x antigen
10/30/2001	US6309636 Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
10/30/2001	CA2090700C Modified antibodies with controlled clearance time
10/30/2001	CA2047843C Method and product for the treatment of gastric disease
10/30/2001	CA2002833C Interferon-gamma binding proteins
10/25/2001	WO2001079557A2 Gtp-binding protein useful in treatment and detection of cancer
10/25/2001	WO2001079555A2 Roles of jak/stat family members in tolerance induction
10/25/2001	WO2001079525A2 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001	WO2001079510A1 Materials and methods relating to immune responses to fusion proteins
10/25/2001	WO2001079494A1 Agonist antibodies
10/25/2001	WO2001079493A1 New lipid binding protein 2
10/25/2001	WO2001079492A2 Lipid binding protein 3
10/25/2001	WO2001079484A2 Method for detecting iodized thyroglobulin in human serum after thyroid ablation

1 ... 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 ... 1494